Daiichi Sankyo
Bryan O'Neill has extensive work experience in the pharmaceutical industry. Bryan started their career at Almac Group as a Project Manager from 2001 to 2003. Bryan then worked at Catalent Pharma Solutions as a Project Manager in 2004. In the same year, they also served as a Clinical Supply Coordinator at Centocor. Bryan joined Abbott in 2007, where they held the positions of Sr. Project Manager and TPM Manager until 2009. Bryan then moved to ImClone Systems, a subsidiary of Eli Lilly and Company, serving as a Sr. Manager, Clinical Supplies from 2009 to 2011 and later as Director, Clinical Supplies from 2011 to 2012. Bryan then worked at Eli Lilly and Company as Director, Clinical Trial Materials & Manufacturing Services & NJ Site Head from 2012 to 2013. From 2013 to 2017, Bryan served as Senior Director and later as Director of Clinical Supply & Logistics at Stemline Therapeutics Inc. Currently, they hold the position of Global Head, Clinical Supply Operations at Daiichi Sankyo, Inc. since 2022.
Bryan O'Neill earned a Bachelor of Science degree in Clinical Psychology from Penn State University between 1997 and 2001.
This person is not in the org chart
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.